Tenofovir News and Research

RSS
Topical delivery of AVR drug combination can provide complete protection against HIV

Topical delivery of AVR drug combination can provide complete protection against HIV

Nearly half of newly-infected HIV patients experience neurologic issues

Nearly half of newly-infected HIV patients experience neurologic issues

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV

Renal risk factors for NA-treated HBV patients identified

Renal risk factors for NA-treated HBV patients identified

Real-world data confirm TDF efficacy for HBV

Real-world data confirm TDF efficacy for HBV

Resistance to prior antiviral agents impacts TDF response

Resistance to prior antiviral agents impacts TDF response

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

ARV drug atazanavir may have significant effects on infant development

ARV drug atazanavir may have significant effects on infant development

Rescue TDF monotherapy effective in multidrug resistant chronic HBV

Rescue TDF monotherapy effective in multidrug resistant chronic HBV

Combining medications may increase HBsAg loss in HBV patients

Combining medications may increase HBsAg loss in HBV patients

Genvoya approved as complete regimen for HIV treatment

Genvoya approved as complete regimen for HIV treatment

Vaginal silicone ring may protect women against HIV, herpes virus

Vaginal silicone ring may protect women against HIV, herpes virus

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

HIV prevention program undergoes “real world” evaluation

HIV prevention program undergoes “real world” evaluation

IP10 levels linked to HBsAg decline during TDF treatment

IP10 levels linked to HBsAg decline during TDF treatment

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

Young, single South African women adhere well to daily PrEP regimen to prevent HIV infection

Young, single South African women adhere well to daily PrEP regimen to prevent HIV infection

Johns Hopkins, IOCB Prague sign drug discovery research agreement

Johns Hopkins, IOCB Prague sign drug discovery research agreement

Baruch S. Blumberg Institute engaged to conduct study using ContraVir's new HBV therapeutic candidate

Baruch S. Blumberg Institute engaged to conduct study using ContraVir's new HBV therapeutic candidate

Telbivudine drug prevents perinatal transmission of HBV

Telbivudine drug prevents perinatal transmission of HBV